ABSTRACT
Background African trypanosomiasis continues to pose a substantial threat to both human and animal health in sub-Saharan Africa. This study examined the prevalence of African trypanosomiasis within human and animal populations in Nigeria, the trypanosome species involved, the spread of animal reservoirs, and the variability in diagnostic methodologies employed.
Methodology/principal findings A scoping review was performed, following the methodological framework outlined in PRISMA-ScR checklist. Eligible studies were explored for disease prevalence, causative parasites, reservoir hosts, and diagnostic techniques used. A total of 16 eligible studies published between 1993 and 2021 were retrieved. 13 studies reported the prevalence of African trypanosomiasis in animals, and 3 for humans. Varying prevalence rates were recorded depending on the host population and diagnostic methods employed. The overall prevalence of Animal African Trypanosomiasis (AAT) and Human African Trypanosomiasis (HAT) was 27.3% (4,404/16,117) and 3.6% (72/1,974) respectively. The highest incidence of HAT was detected using the Card Agglutination Test for Trypanosomiasis (CATT), whereas that of AAT was observed using PCR, followed by microscopy which was the most extensively employed technique in this study. The various diagnostic methods used in various studies showed a variety of sensitivities and specificities, affecting the accuracy of disease detection. Remarkably, domestic animals like cattle, pigs, and dogs were identified as potential reservoirs for the human-infective parasites (T. b. gambiense) in Nigeria.
Conclusion This study highlights the high prevalence rate and complex epidemiology of African trypanosomiasis in humans and animals in Nigeria. These findings underscore the importance of comprehensive measures involving both veterinary and human health sectors to combat African trypanosomiasis effectively in Nigeria. Only few studies have investigated the prevalence of HAT in Nigeria. Hence, adequately coordinated epidemiological surveys are imperative to ascertain the true epidemiological status of HAT in Nigeria and inform targeted intervention policies to achieve WHO’s NTD elimination targets in 2030.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
